Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

(ProRx Pharma) - From hospitals to surgical centers, med spas to even your dentist’s office—chances are, you or someone in your family has already received medication from a compounding pharmacy ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...